SyBridge Technologies, a global industrial technology company, has completed the acquisition of Pyramid Mold and Tool. This transaction, which is SyBridge’s fifth acquisition in the last 10 months, further expands SyBridge’s customer base and footprint in the life sciences end-markets. 

New York based private equity firm Crestview Partners established SyBridge Technologies in 2019 and committed $200 million of equity to create a value-added manufacturing solutions provider spanning across end-markets, geographies, and advanced technological capabilities. 

Located in Rancho Cucamonga, California, Pyramid manufactures precision multicavity plastic injection moulding tools focusing on the life sciences industry while also serving personal care and select industrial markets. The company was founded in 1995 and uses state-of-the-art engineering and manufacturing capabilities to provide precise and effective customer solutions. 

The acquisition of Pyramid expands SyBridge's capabilities to offer highly complex precision tooling solutions for the life sciences and other target industries. As a part of a larger organisation, Pyramid will leverage SyBridge’s design, engineering, supply chain, and production capabilities to better serve and grow with its customers. 

"Pyramid is a terrific company and represents a significant step in SyBridge's journey to build a leading franchise in life sciences manufacturing solutions," said Tony Nardone, CEO of SyBridge. "With this acquisition, SyBridge’s Life Sciences Business Unit now has a strong presence on both the eastern and western parts of North America to better serve our customers. Our strategy will be to continue to grow our life sciences customer base through organic growth and selective acquisitions to expand SyBridge’s capabilities and geographies. 

“Pyramid's superior capabilities in high precision tooling are an ideal fit with our platform and will allow us to better support our customers,” said Bill McDonough, President of SyBridge's Life Sciences Business Unit. 

Part of Rapid News Group

© Rapid Life Sciences Ltd. A Rapid News Group Company. All Rights Reserved